Table 1 |
||
|
Clinical characteristics of the healthy control subjects and patients with RA studied |
||
| Patients with RA (n = 16) |
Control group (n = 16) |
|
|
|
||
| Gender (female/male) |
9/7 |
7/9 |
| Age, years (range) |
63 ± 4.0 (25 to 92) |
53 ± 4.2 (26 to 87) |
| Disease duration, years (range) |
11.4 ± 4.8 (1 to 57) |
n.a. |
| Rheumatoid factor-positive |
11 |
n.a. |
| C-reactive protein (mg/ml) |
35.6 ± 9 |
n.m. |
| CD4/CD8 ratio |
4.4 ± 0.7 |
3.9 ± 0.5 |
| DAS28-3 |
4.73 ± 0.44 |
n.a. |
|
|
||
|
Data are given as means ± standard errors of the mean. DAS28-3, Disease Activity Score using 28 joints and three variables; n.a.; not applicable; n.m.; not measured; RA, rheumatoid arthritis. |
||
|
Wahle et al. Arthritis Research & Therapy 2006 8:R138 doi:10.1186/ar2028 |
||
